• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Radiesse gets FDA nod for facial aesthetics

Article

San Mateo, Calif. - Newly approved Radiesse - billed by manufacturer BioForm Medical as the "next-generation" dermal filler - offers long-lasting correction of moderate-to-severe facial wrinkles and folds, the company says.

San Mateo, Calif. - Newly approved Radiesse - billed by manufacturer BioForm Medical as the "next-generation" dermal filler - offers long-lasting correction of moderate-to-severe facial wrinkles and folds, the company says.

The Food and Drug Administration approved Radiesse for that indication in late December, and also approved use of the filler for long-lasting correction of facial lipoatrophy in patients with HIV.

Radiesse is the first cosmetic filler with a proven 12-month benefit in multiple clinical studies, BioForm Medical President and CEO Steven L. Basta said in a prepared statement.

According to BioForm Medical:

Related Videos
© 2024 MJH Life Sciences

All rights reserved.